StockData
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc (PTGX) stock

PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/30199% above fair value
$127.16+2.49 (+2.00%)

Close on Nov 18, 2026Market cap $8.23BP/E 123.5Yield –

Earnings

Protagonist Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$274.40M
+5738.3% on a year earlier
EPS, Q3 FY2026
$3.07
-$0.62 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Protagonist Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$274.40M+5738.3%$3.07Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$213.50M+3749.6%$2.29Release
Q1 FY2026ended Mar 31, 2026May 5, 2026after the close$56.40M+99.3%$0.05Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$7.40M-95.7%-$0.69Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$4.70M0.0%-$0.62Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025after the close$5.55M+32.0%-$0.55Release
Q1 FY2025ended Mar 31, 2025May 6, 2025after the close$28.30M-88.9%-$0.19Release
Q4 FY2024ended Dec 31, 2024Feb 21, 2025before the open$170.64M+184.4%$1.98Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close$4.70M––Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$4.20M–-$0.50Release
Q1 FY2024ended Mar 31, 2024May 7, 2024after the close$255.00M–$3.26Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Protagonist Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Protagonist Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Protagonist Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Update
  7. Results
  8. Results
  9. Results
  10. News
  11. News
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?